Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Sell
33
RHI Quote, Financials, Valuation and Earnings
Last price:
$47.34
Seasonality move
:
6%
Day range:
$47.02 - $48.20
52-week range:
$40.00 - $78.41
Dividend yield:
4.53%
P/E ratio:
24.08x
P/S ratio:
0.87x
P/B ratio:
3.75x
Volume:
985.1K
Avg. volume:
1.8M
1-year change:
-32.04%
Market cap:
$4.9B
Revenue:
$5.8B
EPS (TTM):
$2.00
Analysts' Opinion
-
Consensus RatingRobert Half has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 6 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $49.30, Robert Half has an estimated upside of 2.37% from its current price of $48.16.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $35.00 representing 27.33% downside risk from its current price of $48.16.
Fair Value
-
According to the consensus of 10 analysts, Robert Half has 2.37% upside to fair value with a price target of $49.30 per share.
RHI vs. S&P 500
-
Over the past 5 trading days, Robert Half has underperformed the S&P 500 by -1.25% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Robert Half does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Robert Half revenues have been falling on a year-over-year basis for 10 quarters in a row. In the most recent quarter Robert Half reported revenues of $1.4B.
Earnings Growth
-
Robert Half earnings have been falling on a year-over-year basis for 10 quarters in a row. In the most recent quarter Robert Half reported earnings per share of $0.17.
Enterprise value:
4.6B
EV / Invested capital:
3.49x
Price / LTM sales:
0.87x
EV / EBIT:
19.12x
EV / Revenue:
0.81x
PEG ratio (5yr expected):
--
EV / Free cash flow:
14.76x
Price / Operating cash flow:
15.87x
Enterprise value / EBITDA:
13.96x
Gross Profit (TTM):
$2.2B
Return On Assets:
7.15%
Net Income Margin (TTM):
3.62%
Return On Equity:
14.32%
Return On Invested Capital:
14.32%
Operating Margin:
2.88%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $7.1B | $6.2B | $5.7B | $1.5B | $1.4B | |
| Gross Profit | $3B | $2.4B | $2.2B | $562.8M | $499M | |
| Operating Income | $854.6M | $368.7M | $239.5M | $40.9M | $38.9M | |
| EBITDA | $935.7M | $468.5M | $327.9M | $63.4M | $60.5M | |
| Diluted EPS | $5.64 | $3.34 | $2.00 | $0.61 | $0.17 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.9B | $2.3B | $2.3B | $2.2B | $2B | |
| Total Assets | $2.6B | $3B | $2.9B | $2.9B | $2.7B | |
| Current Liabilities | $1.1B | $1.3B | $1.1B | $1.2B | $1.2B | |
| Total Liabilities | $1.4B | $1.5B | $1.3B | $1.4B | $1.4B | |
| Total Equity | $1.2B | $1.5B | $1.6B | $1.5B | $1.3B | |
| Total Debt | $181K | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $680.1M | $555.4M | $367M | -$15.9M | -$59.3M | |
| Cash From Investing | -$152.3M | -$71.5M | -$97.8M | -$22M | -$32.7M | |
| Cash From Financing | -$516.6M | -$487M | -$464.3M | -$143.4M | -$111.2M | |
| Free Cash Flow | $624.6M | $507.2M | $310.1M | -$27.7M | -$71.7M | |
RHI
Sector
Market Cap
$4.9B
$610M
Price % of 52-Week High
61.42%
77.25%
Dividend Yield
4.53%
0%
Shareholder Yield
8.3%
2.42%
1-Year Price Total Return
-32.05%
-5.27%
Beta (5-Year)
1.059
0.777
Dividend yield:
4.53%
Annualized payout:
$2.12
Payout ratio:
109.23%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$47.09
200-day SMA
Sell
Level
$62.38
Bollinger Bands (100)
Sell
Level
47.88 - 66.34
Chaikin Money Flow
Buy
Level
336.3M
20-day SMA
Buy
Level
$45.60
Relative Strength Index (RSI14)
Buy
Level
54.08
ADX Line
Sell
Level
26.62
Williams %R
Sell
Level
-6.4407
50-day SMA
Sell
Level
$49.23
MACD (12, 26)
Sell
Level
-0.42
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
68M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.603)
Buy
CA Score
(Annual)
Level (0.7096)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.4636)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.
Stock Forecast FAQ
In the current month, RHI has received 2 Buy ratings 6 Hold ratings, and 2 Sell ratings. The RHI average analyst price target in the past 3 months is $49.30.
-
Where Will Robert Half Stock Be In 1 Year?
According to analysts, the consensus estimate is that Robert Half share price will rise to $49.30 per share over the next 12 months.
-
What Do Analysts Say About Robert Half?
Analysts are divided on their view about Robert Half share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Robert Half is a Sell and believe this share price will drop from its current level to $35.00.
-
What Is Robert Half's Price Target?
The price target for Robert Half over the next 1-year time period is forecast to be $49.30 according to 10 Wall Street analysts, 2 of them rate the stock a Buy, 2 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is RHI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Robert Half is a Hold. 6 of 10 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of RHI?
You can purchase shares of Robert Half via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Robert Half shares.
-
What Is The Robert Half Share Price Today?
Robert Half was last trading at $47.34 per share. This represents the most recent stock quote for Robert Half. Yesterday, Robert Half closed at $48.16 per share.
-
How To Buy Robert Half Stock Online?
In order to purchase Robert Half stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is down 0.79% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 13.42% over the past day.
